Salvianolic acid B inhibits hepatic stellate cell activation and liver fibrosis by targeting PDGFRβ.

[1]  Yongfang Yuan,et al.  Gomisin D alleviates liver fibrosis through targeting PDGFRβ in hepatic stellate cells. , 2023, International journal of biological macromolecules.

[2]  L. Jiang,et al.  Salvianolic acid B suppresses hepatic fibrosis by inhibiting ceramide glucosyltransferase in hepatic stellate cells , 2023, Acta Pharmacologica Sinica.

[3]  Yongfang Yuan,et al.  Salvianolic acid B suppresses hepatic stellate cell activation and liver fibrosis by inhibiting the NF-κB signaling pathway via miR-6499-3p/LncRNA-ROR. , 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[4]  Kaiqun Li,et al.  Endothelial PDGF-BB/PDGFR-β signaling promotes osteoarthritis by enhancing angiogenesis-dependent abnormal subchondral bone formation , 2022, Bone Research.

[5]  Z. Zeng,et al.  A Positive Feedback Loop between Inactive VHL-Triggered Histone Lactylation and PDGFRβ Signaling Drives Clear Cell Renal Cell Carcinoma Progression , 2022, International journal of biological sciences.

[6]  Z. Hong,et al.  In situ synthesis and unidirectional insertion of membrane proteins in liposome-immobilized silica stationary phase for rapid preparation of microaffinity chromatography , 2022, Acta pharmaceutica Sinica. B.

[7]  S. Svegliati,et al.  PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis , 2022, International journal of molecular sciences.

[8]  Yunle Wan,et al.  Mitofusin-2 Restrains Hepatic Stellate Cells' Proliferation via PI3K/Akt Signaling Pathway and Inhibits Liver Fibrosis in Rats , 2022, Journal of healthcare engineering.

[9]  Xukun Deng,et al.  Piperine inhibits AML-12 hepatocyte EMT and LX-2 HSC activation and alleviates mouse liver fibrosis provoked by CCl4: roles in the activation of the Nrf2 cascade and subsequent suppression of the TGF-β1/Smad axis. , 2021, Food & function.

[10]  Pere Ginès,et al.  Liver cirrhosis , 2021, The Lancet.

[11]  W. Shou,et al.  Heterogeneity of Hepatic Stellate Cells in Fibrogenesis of the Liver: Insights from Single-Cell Transcriptomic Analysis in Liver Injury , 2021, Cells.

[12]  Chong Zhang,et al.  Salvianolic acid B protects against acute and chronic liver injury by inhibiting Smad2C/L phosphorylation , 2021, Experimental and therapeutic medicine.

[13]  D. Gong,et al.  PDGF-BB induces conversion, proliferation, migration, and collagen synthesis of oral mucosal fibroblasts through PDGFR-β/PI3K/ AKT signaling pathway. , 2021, Cancer biomarkers : section A of Disease markers.

[14]  J. Demoulin,et al.  PDGF receptor mutations in human diseases , 2021, Cellular and Molecular Life Sciences.

[15]  Ping Liu,et al.  Pharmacological Effects of Salvianolic Acid B Against Oxidative Damage , 2020, Frontiers in Pharmacology.

[16]  A. Ruiz-Margáin,et al.  Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease , 2020, World journal of gastroenterology.

[17]  Yalan Wu,et al.  The Effect of Salvianolic Acid on Vascular Protection and Possible Mechanisms , 2020, Oxidative medicine and cellular longevity.

[18]  B. Wang,et al.  Salvianolic acid B blocks hepatic stellate cell activation via FGF19/FGFR4 signaling. , 2020, Annals of hepatology.

[19]  K. Mekeel,et al.  Liver fibrosis: Pathophysiology and clinical implications , 2020, Wiley interdisciplinary reviews. Systems biology and medicine.

[20]  Xiance Sun,et al.  The Role of Autophagy and NLRP3 Inflammasome in Liver Fibrosis , 2020, BioMed research international.

[21]  Jinghui Zheng,et al.  Effects of salvianolic acid B on liver fibrosis , 2020, Medicine.

[22]  Hui-Zhen Tang,et al.  Research on promoting liver fibrosis injury by the targeted regulation of miR-202 for HGF to activate HSC , 2020, Irish Journal of Medical Science (1971 -).

[23]  E. Crouchet,et al.  Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives , 2020, Cells.

[24]  Chong Zhang,et al.  Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro. , 2019, Life sciences.

[25]  M. Whitfield,et al.  Shared and distinct mechanisms of fibrosis , 2019, Nature Reviews Rheumatology.

[26]  Shuping You,et al.  The Phenylethanol Glycoside Liposome Inhibits PDGF-Induced HSC Activation via Regulation of the FAK/PI3K/Akt Signaling Pathway , 2019, Molecules.

[27]  N. Afdhal,et al.  Liver Fibrosis Determination. , 2019, Gastroenterology clinics of North America.

[28]  F. Tacke,et al.  Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis , 2019, Cells.

[29]  Dongwei Zhang,et al.  Salvia miltiorrhiza in diabetes: A review of its pharmacology, phytochemistry, and safety. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[30]  H. Ren,et al.  Endostatin attenuates PDGF-BB- or TGF-β1-induced HSCs activation via suppressing RhoA/ROCK1 signal pathways , 2019, Drug design, development and therapy.

[31]  G. Kai,et al.  Bioactivities, biosynthesis and biotechnological production of phenolic acids in Salvia miltiorrhiza , 2018, Critical reviews in food science and nutrition.

[32]  R. Shah,et al.  Thymosin β4 inhibits PDGF-BB induced activation, proliferation, and migration of human hepatic stellate cells via its actin-binding domain , 2018, Expert opinion on biological therapy.

[33]  Ni Liu,et al.  Influence of amygdalin on PDG, IGF and PDGFR expression in HSC-T6 cells , 2018, Experimental and therapeutic medicine.

[34]  P. Boor,et al.  PDGF in organ fibrosis. , 2017, Molecular aspects of medicine.

[35]  Qin Chen,et al.  PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics , 2017, Molecular medicine reports.

[36]  S. Nilsson,et al.  New agents in HSC mobilization , 2017, International Journal of Hematology.

[37]  A. Federico,et al.  Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years , 2017, Molecules.

[38]  S. Lydersen,et al.  Risk factors of admission for acute colonic diverticulitis in a population-based cohort study: The North Trondelag Health Study, Norway , 2016, World journal of gastroenterology.

[39]  Qiang Xu,et al.  Targeting the PDGF-B/PDGFR-β Interface with Destruxin A5 to Selectively Block PDGF-BB/PDGFR-ββ Signaling and Attenuate Liver Fibrosis , 2016, EBioMedicine.

[40]  P. Olinga,et al.  Targeted Therapies in Liver Fibrosis: Combining the Best Parts of Platelet-Derived Growth Factor BB and Interferon Gamma , 2015, Front. Med..

[41]  F. Tacke,et al.  Mechanisms of liver fibrosis resolution. , 2015, Journal of hepatology.

[42]  Bicheng Chen,et al.  Salvianolic acid B-induced microRNA-152 inhibits liver fibrosis by attenuating DNMT1-mediated Patched1 methylation , 2015, Journal of cellular and molecular medicine.

[43]  K. Rahman,et al.  Salvia miltiorrhiza: Traditional medicinal uses, chemistry, and pharmacology. , 2015, Chinese journal of natural medicines.

[44]  S. Friedman,et al.  β-PDGF Receptor Expressed by Hepatic Stellate Cells Regulates Fibrosis in Murine Liver Injury, but Not Carcinogenesis , 2015, Journal of hepatology.

[45]  Y. Huang,et al.  Wnt signaling in liver fibrosis: progress, challenges and potential directions. , 2013, Biochimie.

[46]  Cheng Huang,et al.  TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways. , 2013, Toxicology and applied pharmacology.

[47]  C. Lechuga,et al.  TGF-β1 up-regulates the expression of PDGF-β receptor mRNA and induces a delayed PI3K-, AKT-, and p70(S6K) -dependent proliferative response in activated hepatic stellate cells. , 2013, Alcoholism: Clinical and Experimental Research.

[48]  Zhu-ying Guo,et al.  Inhibitory effects of salvianolic acid B on CCl(4)-induced hepatic fibrosis through regulating NF-κB/IκBα signaling. , 2012, Journal of ethnopharmacology.

[49]  S. Friedman,et al.  Pathogenesis of liver fibrosis. , 2011, Annual review of pathology.

[50]  D. Blumenthal,et al.  PDGF‐induced proliferation in human arterial and venous smooth muscle cells: Molecular basis for differential effects of PDGF isoforms , 2011, Journal of cellular biochemistry.

[51]  Yang Cheng,et al.  Effect of salvianolic-acid B on inhibiting MAPK signaling induced by transforming growth factor-β1 in activated rat hepatic stellate cells. , 2010, Journal of ethnopharmacology.

[52]  P. Muriel,et al.  Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid. , 2005, Basic & clinical pharmacology & toxicology.

[53]  J. Bonner,et al.  Regulation of PDGF and its receptors in fibrotic diseases. , 2004, Cytokine & growth factor reviews.

[54]  S. Friedman,et al.  Hepatic fibrosis--role of hepatic stellate cell activation. , 2002, MedGenMed : Medscape general medicine.

[55]  F. Marra,et al.  Cytokine Receptors and Signaling in Hepatic Stellate Cells , 2001, Seminars in liver disease.

[56]  S. Sebti,et al.  Tyrosine phosphorylation of focal adhesion kinase by PDGF is dependent on Ras in human hepatic stellate cells , 2000, Hepatology.